Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 263 results for "vldl"

Global Cholesterol Testing Market

NEW YORK, Oct. 23, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Cholesterol Testing in Million Units by the following Product Segments: Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B, and Other Apolipoprotein Tests. Scottrade, 9 hours ago
[x]  

How grapefruit beats anaemia, obesity, diabetes, by researchers

Can eating whole grapefruit and drinking the juice induce weight loss, lower the risk of developing diabetes and its complications as well treat anaemia? Recent studies by Nigerian and Indian researchers have demonstrated the many therapeutic uses ...
 The Guardian Nigeria1 day ago

Transcriptomic Analysis Unveils Correlations between Regulative Apoptotic Caspases and Genes of Cholesterol Homeostasis in Human Brain

Introduction Caspases were initially discovered as critical enzymes in the control of apoptosis. Quite soon it was evident that, they can supervise additional biological processes, such as inflammation and differentiation [1] , [2] . This discovery ...
 Plosone.org5 days ago

Sweet Poison

No laddoos this Diwali for Hemant. A tech whiz who moved to Bangalore from California after the proceeds from writing a software program on industrial security and some fourteen patents ensured that he and his wife Sharon need not work for the rest ...
 New Indian Express5 days ago

Acasti Pharma loses $3.71-million in Q2

Mr. Andre Godin reports ACASTI ANNOUNCES SECOND QUARTER RESULTS Acasti Pharma Inc. has released its results for the three and six months ended Aug. 31, 2014. "Acasti continues to make important progress in its drug development program to ...
 Stockwatch1 week ago Acasti Announces Second Quarter Results  BusinessWeek1 week ago Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results Proving Statistically Significant Improvements in Triglycerides & Non-HDL-C  Street Sweeper3 weeks ago Acasti Pharmai Reports Successful Capre® Phase 2 TRIFECTA Results Proving Statistically Significant Improvements In Triglycerides & Non-HDL-C  BioSpace3 weeks ago
[x]  

Genomic Determinants of Triglyceride and Cholesterol Distribution into Lipoprotein Fractions in the Rat

by Miloslava Hodúlová, Lucie Šedová, Drahomíra Křenová, František Liška, Michaela Krupková, Ludmila Kazdová, Johanne Tremblay, Pavel Hamet, Vladimír Křen, Ondřej Šeda The plasma profile of major lipoprotein classes and its ...
 Plosone.org2 weeks ago

Extended Exenatide Administration Enhances Lipid Metabolism and Exacerbates Pancreatic Injury in Mice on a High Fat, High Carbohydrate Diet

Abstract This study expanded upon a previous study in mice reporting a link between exenatide treatment and exocrine pancreatic injury by demonstrating temporal and dose responses and providing an initial mechanistic hypothesis. The design of the ...
 Plosone.org2 weeks ago

Good Bad and Ugly Cholesterol (Promoted Health Initiative)

It all started with 'high cholesterol', and then came the 'good' and the 'bad' cholesterols. Now we have the last member of the notorious trio: the 'ugly cholesterol'. The risk of 'ischaemic' heart disease -- the leading cause of death worldwide -- ...
 Times of India2 weeks ago The good, the bad and the ugly cholesterol  Times of India3 weeks ago Promotional: The good, the bad and the ugly cholesterol  Times of India3 weeks ago
Examiner.com

3 Free Fast Weight Loss Diets

Finding free fast weight loss diets that actually work is very difficult for many people because they do not use natural methods. Sadly, these pills or pre-packaged foods are hardly the picture of health. 1. Low Fat Diets Many processed foods ...
 Examiner.com2 weeks ago

Amgen reports positive results of two phase III studies of evolocumab

Amgen has announced data from two phase III studies, RUTHERFORD-2 and TESLA, that showed treatment with evolocumab, a novel investigational low-density lipoprotein cholesterol (LDL-C)-lowering medication, resulted in a statistically significant ...
 Center Watch3 weeks ago The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol  Scottrade3 weeks ago Amgen Release: The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol  BioSpace3 weeks ago Amgen : The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol  4 Traders3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less